2:
A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial.
MacArthur RD, Novak RM, Peng G, Chen L, Xiang Y, Hullsiek KH, Kozal MJ, van den Berg-Wolf M, Henely C, Schmetter B, Dehlinger M; CPCRA 058 Study Team; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
Lancet. 2006 Dec 16;368(9553):2125-35.
PMID: 17174704 [PubMed - indexed for MEDLINE]
Related Articles
8:
A randomized trial comparing the efficacy and tolerability of two HAART strategies at two years in antiretroviral naive patients.
Mallolas J, Blanco JL, Pich J, Arnaiz JA, Peña JM, Dalmau D, de Lazzari E, Ochoa A, Vidal F, Ribas MA, Segura F, Pedrol E, Flores J, Cruceta A, Varea S, Miró JM, Martínez E, Gatell JM.
Rev Clin Esp. 2007 Oct;207(9):427-32.
PMID: 17915162 [PubMed - indexed for MEDLINE]
Related Articles
10:
Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
Skiest DJ, Su Z, Havlir DV, Robertson KR, Coombs RW, Cain P, Peterson T, Krambrink A, Jahed N, McMahon D, Margolis DM; AIDS Clinical Trials Group 5170 Study Team.
J Infect Dis. 2007 May 15;195(10):1426-36. Epub 2007 Apr 6.
PMID: 17436222 [PubMed - indexed for MEDLINE]
Related Articles
11:
Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy.
Kamya MR, Mayanja-Kizza H, Kambugu A, Bakeera-Kitaka S, Semitala F, Mwebaze-Songa P, Castelnuovo B, Schaefer P, Spacek LA, Gasasira AF, Katabira E, Colebunders R, Quinn TC, Ronald A, Thomas DL, Kekitiinwa A; Academic Alliance for AIDS Care and Prevention in Africa.
J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):187-93.
PMID: 17693883 [PubMed - indexed for MEDLINE]
Related Articles
14:
The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis.
Haubrich RH, Kemper CA, Hellmann NS, Keiser PH, Witt MD, Forthal DN, Leedom J, Leibowitz M, Whitcomb JM, Richman D, McCutchan JA; California Collaborative Treatment Group.
AIDS. 2002 Oct 18;16(15):F33-40.
PMID: 12370520 [PubMed - indexed for MEDLINE]
Related Articles